Markus M. Heimesaat

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.

Michael A. Nauck, Markus M. Heimesaat, Jens J. Holst et al. · Journal of Clinical Investigation · 1993 · 1.6K citations · Full text

Medicine, Endocrinology, Pharmacology +15

A guide to histomorphological evaluation of intestinal inflammation in mouse models.

Ulrike Erben, Christoph Loddenkemper, Katja Doerfel et al. · PubMed · 2014 · 688 citations

Medicine, Pathobiology, Pathology +17

Effects of Glucagon-Like Peptide 1 on Counterregulatory Hormone Responses, Cognitive Functions, and Insulin Secretion during Hyperinsulinemic, Stepped Hypoglycemic Clamp Experiments in Healthy Volunteers

Michael A. Nauck, Markus M. Heimesaat, Kai Behle et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 579 citations · Full text

Life Sciences, Endocrinology, Physiology +16

Ly6Chi Monocytes Provide a Link between Antibiotic-Induced Changes in Gut Microbiota and Adult Hippocampal Neurogenesis

Luisa Möhle, Daniele Mattei, Markus M. Heimesaat et al. · Cell Reports · 2016 · 461 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism

Arash Haghikia, Friederike Zimmermann, P. A. Schumann et al. · European Heart Journal · 2021 · 355 citations · Full text

Life Sciences, Immunology, Nutritional Sciences +17